When a Medicare Part D beneficiary adheres to their prescription regimen, both the individual and the broader health care system benefit. The Congressional Budget Office (CBO), for example, now estimates increasing the number of Part D prescriptions filled by just 1 percent reduces program spending on medical services by approximately 0.20 percent. The cost savings are even greater for seniors with certain chronic conditions. Today, we’re looking at congestive heart failure.
A study published in the Journal of Managed Care and Specialty Pharmacy breaks down how patients with congestive heart failure have saved.
Beneficiaries from across the country living with congestive heart failure are reaping the benefits of Medicare Part D. James, of Indiana, for example, had a heart transplant at 66 years old. His Medicare Part D coverage helps him afford the medicines that sustain his transplant, and without the program, he would likely not be able to address both his health and financial challenges. Patricia of California also expressed her gratitude toward Part D, noting without the program’s coverage, she would not be able to afford her prescriptions to manage her heart and blood pressure problems.
A number of patients living with congestive heart failure have shared how Medicare Part D has helped them live longer, healthier lives. Stay tuned in the coming weeks for more #MedicareMonday blogs that continue to address how Medicare Part D helps people with chronic diseases, and if you have a similar success story, we encourage you to share it below!
Read other Medicare Monday posts.
Get updates on Medicare and/or other relevant issues here.
Allyson Funk Ally is a former senior director of public affairs at PhRMA focused on advocacy issues for the biopharmaceutical industry. Her expertise includes Medicare, Medicaid, 340B, health reform and more. Prior to PhRMA, her experience included leading health communications for a large membership organization, supporting public affairs clients and working for the governor of Louisiana.